Hamid, Aning .
HRN: 19-53-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2022
CEFTRIAXONE 1G (VIAL)
07/25/2022
07/31/2022
IV
1 Gram
Q24h
Benign Febrile Seuzure
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes